- Nachrichtendetail
-
11.06.2024 13:04:01 - dpa-AFX: *REGENERON AND SANOFI: FDA APPROVES KEVZARA FOR TREATMENT OF ACTIVE POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
SANOFI SA INHABER EO 2 | 920657 | Xetra | 91,340 | 04.07.24 17:38:10 | +1,100 | +1,22% | 0,000 | 0,000 | 90,520 | 90,240 |
|
Regeneron Pharmaceuticals | 881535 | NASDAQ | 1.024,090 | 03.07.24 20:48:58 | -20,570 | -1,97% | 1.010,000 | 1.034,190 | 1.042,280 | 1.024,090 |
